Literature DB >> 15335195

Quinine-resistant severe falciparum malaria effectively treated with atovaquone and proguanil hydrochloride combination therapy.

Hitoji Uchiyama1, Akio Okamoto, Katsuaki Sato, Tomohiro Yamada, Sadatsugu Murakami, Seiichi Yoneda, Yoshihiro Kajita, Tatsuya Tegoshi, Naoki Arizono.   

Abstract

A 22-year-old Japanese man noticed pyrexia and diarrhea after travel to Guinea. Notable physical findings included hepatosplenomegaly. Treatment with oral quinine and minocycline was started after definitive diagnosis of falciparum malaria by blood smear. Initially, parasitemia and body temperature decreased but by the third night of therapy his temperature increased to 40 degrees C with a slight increase of parasite count. When quinine treatment was changed to atovaquone/proguanil, his temperature dropped immediately and complete plasmodial elimination was confirmed on microscopic examination. Subsequent recrudescence of the disease was not observed. It was concluded that the antimalarial treatment with atovaquone/proguanil might become invaluable in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15335195     DOI: 10.2169/internalmedicine.43.624

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Minocycline impedes African trypanosome invasion of the brain in a murine model.

Authors:  Willias Masocha; Martin E Rottenberg; Krister Kristensson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Atovaquone/Proguanil : A New Drug Combination to Combat Malaria.

Authors:  M S Mustafa; V K Agrawal
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Malaria epidemiology and anti-malarial drug efficacy in Guinea: a review of clinical and molecular studies.

Authors:  Mahamoud Sama Cherif; Prabin Dahal; Abdoul Habib Beavogui; Alexandre Delamou; Eugene Kaman Lama; Alioune Camara; Mamadou Pathe Diallo
Journal:  Malar J       Date:  2021-06-16       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.